Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleNuclear Oncology

Technetium-99m-Labeled HL91 to Identify Tumor Hypoxia: Correlation with Fluorine-18-FDG

Gary J.R. Cook, Stephen Houston, Sally F. Barrington and Ignac Fogelman
Journal of Nuclear Medicine January 1998, 39 (1) 99-103;
Gary J.R. Cook
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Houston
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sally F. Barrington
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ignac Fogelman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 39, Issue 1
January 1, 1998
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Technetium-99m-Labeled HL91 to Identify Tumor Hypoxia: Correlation with Fluorine-18-FDG
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Technetium-99m-Labeled HL91 to Identify Tumor Hypoxia: Correlation with Fluorine-18-FDG
Gary J.R. Cook, Stephen Houston, Sally F. Barrington, Ignac Fogelman
Journal of Nuclear Medicine Jan 1998, 39 (1) 99-103;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Technetium-99m-Labeled HL91 to Identify Tumor Hypoxia: Correlation with Fluorine-18-FDG
Gary J.R. Cook, Stephen Houston, Sally F. Barrington, Ignac Fogelman
Journal of Nuclear Medicine Jan 1998, 39 (1) 99-103;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models
  • Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET
  • Oncological molecular imaging: nuclear medicine techniques
  • Delineation of Hypoxia in Canine Myocardium Using PET and Copper(II)-Diacetyl-bis(N4-Methylthiosemicarbazone)
  • Scintigraphic Imaging of the Hypoxia Marker 99mTechnetium-labeled 2,2''-(1,4-Diaminobutane)bis(2-methyl-3-butanone) Dioxime (99mTc-labeled HL-91; Prognox): Noninvasive Detection of Tumor Response to the Antivascular Agent 5,6-Dimethylxanthenone-4-acetic Acid
  • Google Scholar

More in this TOC Section

  • Dose Escalation Trial of Indium-111-Labeled Anti-Carcinoembryonic Antigen Chimeric Monoclonal Antibody (Chimeric T84.66) in Presurgical Colorectal Cancer Patients
  • Optimized Conditions for Chelation of Yttrium-90-DOTA Immunoconjugates
  • Quantifying the Radiation Dosage to Individual Skeletal Lesions Treated with Samarium-153-EDTMP
Show more Nuclear Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire